Analysis of the literature shows that breast cancer accounts for about 13.5% of all cancer-associated deaths in women, with an increasing trend in frequency [ 3 ].
← all excerpts
Withaferin-A Inhibits Growth of Drug-Resistant Breast Carcinoma by Inducing Apoptosis and Autophagy, Endogenous Reactive Oxygen Species (ROS) Production, and Inhibition of Cell Migration and Nuclear Factor kappa B (Nf-κB)/Mammalian Target of Rapamycin (m-TOR) Signalling Pathway.
1
—
—